NCT04834687 is a NA clinical trial of Exercise in Cardiometabolic Risk, sponsored by Sun Yat-sen University.

Who is sponsoring NCT04834687?

NCT04834687 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT04834687?

Interventions in NCT04834687: Exercise, Diet.

What condition does NCT04834687 study?

NCT04834687 studies Cardiometabolic Risk, Executive Function, Intestinal Microbiome.

Is NCT04834687 still recruiting?

NCT04834687 is currently status unknown. Last updated 22 September 2021.

Last reviewed 2021-09-22 · How we verify

NCT04834687

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Diet and Exercise Interventions on Cardiometabolic Risk Markers, Executive Function, and Intestinal Flora

Status unknown NA Last updated 22 September 2021

What this trial tests

NA trial testing Exercise in Cardiometabolic Risk in 200 participants. Status unknown.

Timeline

2 April 2021

Primary endpoint
31 December 2022

28 February 2023

Quick facts

Lead sponsor	Sun Yat-sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	200
Start date	2 April 2021
Primary completion	31 December 2022
Estimated completion	28 February 2023
Sites	1 location across China

Drugs / interventions tested

Exercise
Diet

Conditions studied

Cardiometabolic Risk — all drugs for Cardiometabolic Risk →
Executive Function — all drugs for Executive Function →
Intestinal Microbiome — all drugs for Intestinal Microbiome →

Sponsor

Sun Yat-sen University

Who can join

Adults 17 to 24, any sex, with Cardiometabolic Risk or Executive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to estimate the effects of diet and exercise interventions on body weight, cardiovascular metabolic markers, executive function, and intestinal flora among undergraduate students, as well as the underlying mechanisms.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

The Effect of Intermittent Fasting on Appetite: A Systematic Review and Meta-Analysis.
Elsworth RL, Monge A, Perry R, Hinton EC, et al · · 2023 · cited 17× · PMID 37299567 · DOI 10.3390/nu15112604
High-fiber diet and rope-skipping benefit cardiometabolic health and modulate gut microbiota in young adults: A randomized controlled trial.
Lin Z, Zhang X, Wu M, Ming Y, et al · · 2023 · cited 10× · PMID 37803759 · DOI 10.1016/j.foodres.2023.113421
Fasting and Exercise in Oncology: Potential Synergism of Combined Interventions.
Wilson RL, Kang DW, Christopher CN, Crane TE, et al · · 2021 · cited 5× · PMID 34684421 · DOI 10.3390/nu13103421
Comparison of diet and exercise on cardiometabolic factors in young adults with overweight/obesity: multiomics analysis and gut microbiota prediction, a randomized controlled trial.
Lin Z, Li T, Huang F, Wu M, et al · · 2025 · cited 4× · PMID 39802638 · DOI 10.1002/mco2.70044
High-fiber diet and rope-skipping benefit cardiometabolic health and modulate gut microbiota in young adults: A randomized controlled trial
Lin Z, Zhang X, Wu M, Ming Y, et al · · 2023

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07589725 — Mulligan Mobilization in Lateral Elbow Tendinopathy · NA · not yet recruiting
NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT06627569 — Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans · NA · not yet recruiting

Other recruiting trials for Cardiometabolic Risk

Currently open trials in the same condition.

NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
NCT07114991 — E-Bike Commuting and Health in Overweight College Students · NA · active not recruiting
NCT06538831 — Impact of Ultra-processed Foods on Cardiometabolic Risk Factors · NA · recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04834687 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 22 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing